Success stories Archive - Page 33 sur 45 - Prestwick Chemical Libraries

success-story

Success Stories


Publications
A rapid, inexpensive high throughput screen method for neurite outgrowth.

Current chemical genomics

Yeyeodu ST, Witherspoon SM, Gilyazova N, Ibeanu GC
Current chemical genomics - vol. 4 74-83 (2010)

Neurite outgrowth assays are the most common phenotypic screen to assess chemical effects on neuronal cells. Current automated assays involve expensive equipment, lengthy sample preparation and handling, costly reagents and slow rates of data acquisition and analysis. We have developed a high throughput screen (HTS) for neurite outgrowth using a robust neuronal cell model coupled […]

Publications
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.

Molecular pharmacology

Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, Adler MW, Seltzman HH, Reggio PH, Heynen-Genel S, Sauer M, Chung TDY, Bai Y, Chen W, Caron MG, Barak LS, Abood ME
Molecular pharmacology - vol. 78 560-568 (2010)

Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and lysophosphatidic acids. Their relatively low affinities for GPR35 and prominent off-target effects at other pathways, however, diminish their utility for understanding GPR35 signaling and for identifying potential therapeutic uses of GPR35. In a screen of the Prestwick Library of drugs […]

Publications
A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors.

Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening

Schaertl S, Prime M, Wityak J, Dominguez C, Munoz-Sanjuan I, Pacifici RE, Courtney S, Scheel A, Macdonald D
Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening - vol. 15 478-487 (2010)

Huntington’s disease (HD) is associated with increased expression levels and activity of tissue transglutaminase (TG2), an enzyme primarily known for its cross-linking of proteins. To validate TG2 as a therapeutic target for HD in transgenic models and for eventual clinical development, a selective and brain-permeable inhibitor is required. Here, a comprehensive profiling platform of biochemical […]

Publications
A repurposing strategy identifies novel synergistic inhibitors of plasmodium falciparum heat shock protein 90

Journal of Medicinal Chemistry

Shahinas D, Liang M, Datti A, Pillai DR
Journal of Medicinal Chemistry - vol. 53 3552-3557 (2010)

Malaria is responsible for 3 million deaths annually. Antimalarial drug resistance is widespread, and few novel, well-defined targets exist. A robotic high throughput screen (HTS) was performed using 4000 small molecules from a natural compound (Spectrum), pharmacologically active (Lopac), and Food and Drug Administration (FDA) approved drug library (Prestwick) for competitive inhibition of the ATP-binding […]

Publications
Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

Bioorganic & medicinal chemistry

Talele TT, Arora P, Kulkarni SS, Patel MR, Singh S, Chudayeu M, Kaushik-Basu N
Bioorganic & medicinal chemistry - vol. 18 4630-4638 (2010)

Hepatitis C virus (HCV) NS5B polymerase is a key target for the development of therapeutic agents aimed at the treatment of HCV infections. Here we report on the identification of novel allosteric inhibitors of HCV NS5B through a combination of structure-based virtual screening, synthesis and structure-activity relationship (SAR) optimization approach. Virtual screening of 260,000 compounds […]

Publications
High-content assay to identify inhibitors of dengue virus infection.

Assay and drug development technologies

Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, Stein DA, Nelson JA, Früh K, Djaballah H
Assay and drug development technologies - vol. 8 553-70 (2010)

Dengue virus (DENV) infections are vectored by mosquitoes and constitute one of the most prevalent infectious diseases in many parts of the world, affecting millions of people annually. Current treatments for DENV infections are nonspecific and largely ineffective. In this study, we describe the adaptation of a high-content cell-based assay for screening against DENV-infected cells […]

Publications
Modeling Liver-Related Adverse Effects of Drugs Using k Nearest Neighbor Quantitative Structure – Activity Relationship Method

Chemical research in toxicology

Rodgers AD, Zhu H, Fourches D, Rusyn I, Tropsha A, Hill C, Carolina N
Chemical research in toxicology - vol. 23 724-732 (2010)

Adverse effects of drugs (AEDs) continue to be a major cause of drug withdrawals in both development and postmarketing. While liver-related AEDs are a major concern for drug safety, there are few in silico models for predicting human liver toxicity for drug candidates. We have applied the quantitative structure-activity relationship (QSAR) approach tomodel liver AEDs. […]

Publications
NIH Public Access

Manuscript A, Syndromes GP
- vol. 48 1-6 (2010)

Publications
Advances in flow cytometry for drug screening

Expert opinion on drug discovery

Peluso J, Muller CD
Expert opinion on drug discovery - vol. 5 827-833 (2010)

Importance of the field: Flow cytometry is considered today as a mature technology. Recently, it has become an accurate tool for screening applications. Yet, not many studies have been published emphasizing flow cytometry as a tool of choice for drug screening except multiplex bead assay. Areas covered in this review: Scanning the literature for technology […]

Publications
Rapid behavior-based identification of neuroactive small molecules in the zebrafish

Nat Chem Biol

Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, Macrae CA, Shoichet B, Peterson RT
Nat Chem Biol - vol. 6 231-237 (2010)

Neuroactive small molecules are indispensable tools for treating mental illnesses and dissecting nervous system function. However, it has been difficult to discover novel neuroactive drugs. Here, we describe a high-throughput, behavior-based approach to neuroactive small molecule discovery in the zebrafish. We used automated screening assays to evaluate thousands of chemical compounds and found that diverse […]